KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Ionis Pharmaceuticals (IONS) over the last 11 years, with Q3 2025 value amounting to $363000.0.

  • Ionis Pharmaceuticals' Other Non Operating Income rose 15563.38% to $363000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1288.52%. This contributed to the annual value of $1.3 million for FY2024, which is 9057.94% down from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Other Non Operating Income stood at $363000.0 for Q3 2025, which was up 15563.38% from $102000.0 recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Other Non Operating Income registered a high of $11.2 million during Q2 2023, and its lowest value of -$12.3 million during Q2 2022.
  • Its 5-year average for Other Non Operating Income is $1315.8, with a median of $277000.0 in 2024.
  • In the last 5 years, Ionis Pharmaceuticals' Other Non Operating Income tumbled by 581677.85% in 2021 and then skyrocketed by 613333.33% in 2022.
  • Ionis Pharmaceuticals' Other Non Operating Income (Quarter) stood at -$477000.0 in 2021, then surged by 236.06% to $649000.0 in 2022, then plummeted by 38.52% to $399000.0 in 2023, then decreased by 21.3% to $314000.0 in 2024, then rose by 15.61% to $363000.0 in 2025.
  • Its Other Non Operating Income was $363000.0 in Q3 2025, compared to $102000.0 in Q2 2025 and $465000.0 in Q1 2025.